{"entity":{"id":"da-biogen","kind":"company","name":"Biogen","aka":[],"tldr":"Biogen partnered on lecanemab and previously marketed aducanumab.","summary":"Aducanumab’s withdrawn indication is recorded on the product page so history is not mistaken for a current option.","asOf":"2026-09-21","links":[{"label":"Biogen","url":"https://www.biogen.com/"}],"tags":["dementia-atlas"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["da-lecanemab","da-aducanumab"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Cambridge, MA","country":"US","companyType":"pharma","website":"https://www.biogen.com/","investors":[],"funding":[]},"route":"/companies/da-biogen/","neighbours":{"drug":[{"id":"da-aducanumab","kind":"drug","name":"Aducanumab","route":"/drugs/da-aducanumab/"},{"id":"da-lecanemab","kind":"drug","name":"Lecanemab","route":"/drugs/da-lecanemab/"}],"cancer":[{"id":"alzheimers-disease","kind":"cancer","name":"Alzheimer’s disease","route":"/diagnoses/alzheimers-disease/"}],"trial":[{"id":"da-trial-clarity-ad","kind":"trial","name":"CLARITY AD","route":"/trials/da-trial-clarity-ad/"},{"id":"da-trial-engage","kind":"trial","name":"ENGAGE","route":"/trials/da-trial-engage/"}]}}